Home » Topics » BioWorld Science

BioWorld Science
RSS

Researchers suggest ZEB2 targeting as an approach for atherosclerosis

Jan. 18, 2022

VelociT mouse model for analyzing T-cell function in human disease

Jan. 18, 2022

PEGylated circularly permuted capsule depolymerase enzyme protects mice from anthrax infection

Jan. 18, 2022

SCN5A tied to drug-induced cardiac arrythmia

Jan. 18, 2022

TCR-modified T cells targeting TdT show antileukemia promise in vivo

Jan. 18, 2022

Universite de Franche-Comte presents compounds targeting histamine H3 receptors

Jan. 18, 2022

Purdue Research Foundation patents protein kinase inhibitors

Jan. 18, 2022

Insulin is tissue-specific, with link to weight complex

Jan. 18, 2022

Novel cdkl5-mutated zebrafish model of CDKL5 deficiency disorder

Jan. 18, 2022

Novel genes identified with risk of obsessive-compulsive disorder

Jan. 17, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...